Poll: Americans Aghast Over Drug Costs But Aren鈥檛 Holding Their Breath For A Fix
Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation鈥檚 capital, according to the Kaiser Family Foundation.
Drugs
1,021-1,040 of 1,313 results
-
-
Graphic: Opioid Painkiller Is Top Prescription In 10 States
Though opioid prescriptions appear to be on the聽decline, Vicodin and Norco remain popular, especially in the South. In more than half of states, Synthroid 鈥 a drug to treat hypothyroidism 鈥 came in at No. 1.
By Jenny Gold -
Congress Tackles The Opioid Epidemic. But How Much Will It Help?
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
-
Bill Of The Month: For Toenail Fungus, A $1,500 Prescription
How a prescription wiped out one woman鈥檚 health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don鈥檛) with medical costs.
-
The Other Opioid Crisis: Hospital Shortages Lead To Patient Pain, Medical Errors
A nationwide shortage of injectable opioid painkillers has left hospitals scrambling to find alternatives 鈥 in some cases leading to dosage mistakes that may harm patients.
-
Use Of HIV-Prevention Drug Grows, But Lags Among Non-Whites
The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years 鈥 but primarily among a white demographic.
By Anna Gorman -
Opioid Maker Funds Efforts To Fight Addiction: Is It 鈥楤lood Money鈥 Or Charity?
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it 鈥 or at least salvage its own reputation.
By Jenny Gold -
Lifting Therapy Caps Is A Load Off Medicare Patients鈥 Shoulders
Last month鈥檚 budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.
By Susan Jaffe -
Patients Overpay For Prescriptions 23% Of The Time, Analysis Shows
Researchers at the University of Southern California analyzed millions of prescriptions and concluded that close to a quarter paid copays that exceeded the cost of the drugs.
-
A Battered Doctor, A Slain Patient And A Family鈥檚 Quest For Answers
An addiction-treatment physician fatally shot a troubled ex-Marine after the man pummeled him inside his California office, police records show. The tragedy illustrates how the limited number of clinics available to prescribe buprenorphine, a drug that all but erases opioid withdrawal, can become crowded, chaotic and dangerous.
By Brian Rinker -
Black Men鈥檚 Blood Pressure Is Cut Along With Their Hair
A new study shows that educational sessions about high blood pressure at African American barbershops, coupled with prescribing and helping to manage medication, reduced hypertension rates significantly.
By Susan Abram -
Rising Health Costs, Soaring Drug Prices, Confusing Bills! What鈥檚 A Consumer To Do?
KHN correspondent Shefali Luthra answered a wide variety of questions about health care in a Reddit 鈥淎sk Me Anything鈥 chat.
-
Campus Voices: Should Student Health Centers Offer Abortion Pills?
California lawmakers are considering a bill that would require student health centers at all of the state鈥檚 four-year public universities to carry the abortion pill. Students at campuses across the state sounded off on the proposal.
By Ana B. Ibarra and Anna Gorman -
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 HHS Leaders Take To The Stump
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and new podcast panelist Anna Edney of Bloomberg News discuss this week鈥檚 spate of speeches by the leaders of the Department of Health and Human Services. They also discuss the slow progress on health legislation on Capitol Hill intended to fund the government and stabilize the individual insurance market. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
-
Of 鈥楳iracles鈥 And Money: Why Hemophilia Drugs Are So Expensive
The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn鈥檛 worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.
By Jenny Gold -
Jury’s In: Opioids Are Not Better Than Other Medicines For Chronic Pain
A new study followed patients with severe chronic pain for a year and found that opioids relieved pain and increased function no better than common drugs like acetaminophen and lidocaine. But the opioids carry the risk of more serious side effects, including addiction and death.
-
States Strive To Curb Costs For A Crucial 鈥 But Exorbitant 鈥 Hemophilia Treatment
Saving the lives of people with the bleeding disorder can require high doses of expensive blood-clotting factor. Taxpayers foot much of the bill as manufacturers profit enormously.
-
Cartoon Mascot Masks Nasty Health Care Feud
California鈥檚 health insurers trotted out a heart-healthy character with an ulterior motive 鈥 taking a dig at drugmakers.
-
In An Effort To Curb Drug Costs, States Advance Bills To Prod Feds On Importation
Legislatures in blue and red states alike are considering proposals that would allow them to import prescription drugs from Canada.
-
FDA Head Vows To Tackle High Drug Prices And Drugmakers 鈥楪aming The System鈥
In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he鈥檚 doing to spur competition and bring down drug prices.
By Sarah Jane Tribble and Liz Szabo